a.correia
Submits third-party assay reports on material purchased directly. Based in Genoa.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.41%
n=7
Suppliers covered
5
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042797 | Selank | GGPeps | GGPE-2602-G2056 | Medutest | 2026-Q3 | 98.46 | 7.92 | — | Buyer-sourced | 0 | FAIL |
| AX-2026-042716 | Retatrutide | GGPeps | GGPE-2511-W9618 | Janoshik | 2026-Q1 | 97.62 | 6.19 | 95.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043407 | Semaglutide | WXT | WXT-2505-E4164 | Medutest | 2025-Q4 | 97.45 | 2.65 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021001 | IGF-1 LR3 | WXT | WXT-2508-G4016 | Janoshik | 2025-Q3 | 96.93 | 4.09 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019149 | Ipamorelin | TFC | TFC-2408-T4425 | Medutest | 2025-Q1 | 99.16 | 3.70 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020723 | GHRP-6 | SGN | SGN-2411-N9088 | Janoshik | 2025-Q1 | 98.41 | 3.98 | 107.0 | Buyer-sourced | 1 | FAIL |
| AX-2024-004426 | Tirzepatide | QSC | QSC-2402-H8701 | Janoshik | 2024-Q1 | 99.58 | 1.75 | 88.9 | Supplier-supplied | 2 | MARGINAL |